Phase 2 Study to Assess the Safety and Efficacy of ANG003
for Exocrine Pancreatic Insufficiency (EPI)
26 locations incl. Long Beach
Sponsor: Anagram Therapeutics, Inc.
Sex: All·Age: 12+
Code: NCT07450547·Phase 2·Recruiting·Listed Mar 2026
University of Michigan
Clinical research site in Ann Arbor, Michigan · 1500 E MEDICAL CENTER DR, ANN ARBOR, MI 48109-5000 · (734) 615-9888
Part of University of Michigan
As of September 2026, 424 paid clinical trials are recruiting at University of Michigan in Ann Arbor, Michigan. Active studies at this site cover conditions such as Healthy, Heart Failure and Acute Kidney Injury. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
New trial at University of Michigan? We'll email you when one opens.
Recruiting clinical trials at University of Michigan (424)
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
for Hepatitis
85 locations incl. Birmingham
Sponsor: Bausch Health Americas, Inc.
Sex: All·Age: 18+
Code: NCT07428538·Phase 3·Recruiting·Listed Feb 2026
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
for Parkinson's Disease
26 locations incl. Phoenix
Sponsor: Bayer
Sex: All·Age: 45 - 75
Code: NCT07330258·Recruiting·Listed Jan 2026
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
for Diabetic Kidney Disease (DKD)
58 locations incl. Huntsville
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18 - 80
Code: NCT07271186·Phase 2·Recruiting·Listed Dec 2025
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
for Melanoma
91 locations incl. Chandler
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06246916·Phase 3·Recruiting·Listed Feb 2024
A Study of Dotinurad Versus Allopurinol in Participants With Gout
for Gout
70 locations incl. Birmingham
Sponsor: Crystalys Therapeutics
Sex: All·Age: 18 - 75
Code: NCT07089875·Phase 3·Recruiting·Listed Jul 2025
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
for Triple-Negative Breast Cancer
82 locations incl. Mobile
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06393374·Phase 3·Recruiting·Listed May 2024
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for Colorectal Neoplasms
81 locations incl. Gilbert
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06662786·Phase 3·Recruiting·Listed Oct 2024
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
for Carcinoma, Non-Small-Cell Lung
88 locations incl. Huntsville
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06119581·Phase 3·Recruiting·Listed Nov 2023
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
for Crohn's Disease
71 locations incl. Sun City
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 16 - 80
Code: NCT06430801·Phase 3·Recruiting·Listed May 2024
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
for COVID-19 Infection
66 locations incl. Canoga Park
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07013474·Phase 3·Recruiting·Listed Jun 2025
Assessment of CCM in HF With Higher Ejection Fraction
for Heart Failure
76 locations incl. Birmingham
Sponsor: Impulse Dynamics
Sex: All·Age: 18+
Code: NCT05064709·Recruiting·Listed Oct 2021
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
for Acute Myeloid Leukemia (AML)
42 locations incl. Gilbert
Sponsor: Kura Oncology, Inc.
Sex: All·Age: 18+
Code: NCT07007312·Phase 3·Recruiting·Listed Jun 2025
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for PIK3CA Mutation
52 locations incl. Gilbert
Sponsor: Relay Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06982521·Phase 3·Recruiting·Listed May 2025
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
for Chronic Kidney Disease
27 locations incl. Birmingham
Sponsor: Boehringer Ingelheim
Sex: All·Age: 2 - 17
Code: NCT07107945·Phase 3·Recruiting·Listed Aug 2025
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
for Refractory Angina
66 locations incl. Phoenix
Sponsor: Shockwave Medical, Inc.
Sex: All·Age: 18+
Code: NCT05102019·Recruiting·Listed Nov 2021
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
for Mantle Cell Lymphoma
41 locations incl. Birmingham
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT06742996·Phase 3·Recruiting·Listed Dec 2024
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
for Multiple Myeloma
66 locations incl. Gilbert
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT05552222·Phase 3·Recruiting·Listed Sep 2022
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
for Metastatic Breast Cancer
26 locations incl. Cerritos
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06324357·Phase 1, Phase 2·Recruiting·Listed Mar 2024
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
for Primary Generalized Tonic-Clonic Seizures
48 locations incl. Mobile
Sponsor: Xenon Pharmaceuticals Inc.
Sex: All·Age: 12+
Code: NCT05667142·Phase 3·Recruiting·Listed Dec 2022
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
for Coronary Arterial Disease (CAD)
46 locations incl. Jonesboro
Sponsor: Boston Scientific Corporation
Sex: All·Age: 18+
Code: NCT06959524·Recruiting·Listed May 2025
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for Prostate Cancer
49 locations incl. Phoenix
Sponsor: Merck Sharp & Dohme LLC
Sex: Male·Age: 18+
Code: NCT06925737·Phase 3·Recruiting·Listed Apr 2025
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
for Autosomal Dominant Polycystic Kidney Disease
37 locations incl. Birmingham
Sponsor: Calico Life Sciences LLC
Sex: All·Age: 18 - 55
Code: NCT06902558·Phase 2·Recruiting·Listed Mar 2025
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
for Melanoma, Cutaneous Malignant
43 locations incl. Phoenix
Sponsor: Immatics US, Inc.
Sex: All·Age: 18+
Code: NCT06743126·Phase 3·Recruiting·Listed Dec 2024
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
for Adjustment Disorder
32 locations incl. Birmingham
Sponsor: Reunion Neuroscience Inc
Sex: All·Age: 18 - 80
Code: NCT07002034·Phase 2·Recruiting·Listed Jun 2025
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
for Stroke
31 locations incl. La Jolla
Sponsor: W.L.Gore & Associates
Sex: All·Age: 18 - 70
Code: NCT03821129·Recruiting·Listed Jan 2019
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
for Idiopathic Inflammatory Myopathy
31 locations incl. Orange
Sponsor: Cabaletta Bio
Sex: All·Age: 6 - 75
Code: NCT06154252·Phase 2, Phase 3·Recruiting·Listed Dec 2023
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
for Cardiovascular Diseases
47 locations incl. Birmingham
Sponsor: BrioHealth Solutions, Inc.
Sex: All·Age: 18 - 100
Code: NCT06310031·Recruiting·Listed Mar 2024
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
for Tricuspid Regurgitation
46 locations incl. Irvine
Sponsor: Edwards Lifesciences
Sex: All·Age: 18+
Code: NCT04097145·Recruiting·Listed Sep 2019
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
for Chronic Graft-versus-host-disease
36 locations incl. Birmingham
Sponsor: Incyte Corporation
Sex: All·Age: 12+
Code: NCT06585774·Phase 3·Recruiting·Listed Sep 2024
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
for Platinum-resistant Ovarian Cancer
33 locations incl. Mobile
Sponsor: Genelux Corporation
Sex: Female·Age: 18+
Code: NCT05281471·Phase 3·Recruiting·Listed Mar 2022
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
for Myelofibrosis
30 locations incl. Birmingham
Sponsor: Sumitomo Pharma America, Inc.
Sex: All·Age: 18+
Code: NCT04176198·Phase 1, Phase 2·Recruiting·Listed Nov 2019
Pompe Disease Registry Protocol
for Glycogen Storage Disease Type II
74 locations incl. Birmingham
Sponsor: Genzyme, a Sanofi Company
Sex: All·Age: All ages
Code: NCT00231400·Recruiting·Listed Oct 2005
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
for Non-small Cell Lung Cancer
23 locations incl. Los Angeles
Sponsor: Genentech, Inc.
Sex: All·Age: 18+
Code: NCT04302025·Phase 2·Recruiting·Listed Mar 2020
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
for Heart Failure - NYHA II - IV
38 locations incl. Huntsville
Sponsor: Boston Scientific Corporation
Sex: All·Age: 18+
Code: NCT07069738·Recruiting·Listed Jul 2025
Fabry Disease Registry & Pregnancy Sub-registry
for Fabry Disease
74 locations incl. Birmingham
Sponsor: Genzyme, a Sanofi Company
Sex: All·Age: All ages
Code: NCT00196742·Recruiting·Listed Sep 2005
DALY II USA/ MB-CART2019.1 for DLBCL
for Refractory Diffuse Large B Cell Lymphoma (DLBCL)
28 locations incl. Birmingham
Sponsor: Miltenyi Biomedicine GmbH
Sex: All·Age: 18+
Code: NCT04792489·Phase 2·Recruiting·Listed Mar 2021
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
for Aortic Regurgitation
29 locations incl. Burlingame
Sponsor: JenaValve Technology, Inc.
Sex: All·Age: All ages
Code: NCT06608823·Recruiting·Listed Sep 2024
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
for Pulmonary Hypertension
32 locations incl. Birmingham
Sponsor: Tempus AI
Sex: All·Age: 18+
Code: NCT06911632·Recruiting·Listed Apr 2025
A Study to Assess Growth in Children With Idiopathic Short Stature
for Idiopathic Short Stature
30 locations incl. Los Angeles
Sponsor: BioMarin Pharmaceutical
Sex: All·Age: 2 - 16
Code: NCT06309979·Recruiting·Listed Mar 2024
Showing the 40 most relevant of 424 recruiting trials at this site. Browse all with filters →
Get new-trial alerts for University of Michigan
We'll email you whenever a new clinical trial starts recruiting at this research site in Ann Arbor, MI. Unsubscribe anytime.
More research sites in Ann Arbor
- University of Michigan Rogel Cancer Center (79 trials)
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor (65 trials)
- C S Mott Children's Hospital (29 trials)
- University of Michigan Comprehensive Cancer Center (27 trials)
- University of Michigan Health System (23 trials)
- VA Ann Arbor Healthcare System, Ann Arbor, MI (23 trials)
- C.S. Mott Children's Hospital (18 trials)
- University of Michigan Hospital (14 trials)
- University of Michigan School of Dentistry (9 trials)
- University of Michigan Health (8 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in Ann Arbor, MI · Michigan clinical trials